SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-010178
Filing Date
2022-06-22
Accepted
2022-06-22 16:14:33
Documents
12
Period of Report
2022-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enfn-20220616x8k.htm   iXBRL 8-K 55425
  Complete submission text file 0001558370-22-010178.txt   180045

Data Files

Seq Description Document Type Size
2 EX-101.SCH enfn-20220616.xsd EX-101.SCH 3037
3 EX-101.LAB enfn-20220616_lab.xml EX-101.LAB 16584
4 EX-101.PRE enfn-20220616_pre.xml EX-101.PRE 10717
6 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20220616x8k_htm.xml XML 5062
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 221032216
SIC: 7372 Services-Prepackaged Software